Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $4,936,615 | $5,000,777 | $5,029,182 | $4,835,079 |
| - Cash | $2,175,662 | $2,000,843 | $1,689,041 | $2,242,889 |
| + Debt | $2,370,111 | $2,848,797 | $2,977,762 | $3,200,261 |
| Enterprise Value | $5,131,064 | $5,848,731 | $6,317,902 | $5,792,451 |
| Revenue | $1,423,097 | $1,394,250 | $1,211,789 | $1,231,523 |
| % Growth | 2.1% | 15.1% | -1.6% | – |
| Gross Profit | $496,807 | $381,182 | $405,156 | $362,743 |
| % Margin | 34.9% | 27.3% | 33.4% | 29.5% |
| EBITDA | $322,932 | $200,686 | -$130,336 | $180,951 |
| % Margin | 22.7% | 14.4% | -10.8% | 14.7% |
| Net Income | $265,260 | $156,590 | -$133,372 | $116,430 |
| % Margin | 18.6% | 11.2% | -11% | 9.5% |
| EPS Diluted | 0.18 | 0.11 | -0.091 | 0.079 |
| % Growth | 63.6% | 221% | -214.5% | – |
| Operating Cash Flow | $504,776 | $544,032 | $0 | $0 |
| Capital Expenditures | -$39,949 | -$41,013 | -$62,495 | -$52,927 |
| Free Cash Flow | $464,827 | $503,019 | $339,498 | $444,370 |